Singular Genomics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

Rhea-AI Summary

Singular Genomics Systems, Inc. (Nasdaq: OMIC) announced its participation in the Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually on August 31, 2022, at 7:30 a.m. PT / 10:30 a.m. ET. The event will feature a presentation by Singular Genomics' management, and interested parties can register for a live webcast. The company specializes in next-generation sequencing (NGS) and multiomics technologies, aiming to empower researchers and clinicians with its G4 Sequencing Platform and developing PX system.

SAN DIEGO, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced plans to present at the Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually.

Singular Genomics’ management is scheduled to present on Wednesday, August 31, 2022, at 7:30 a.m. Pacific Time / 10:30 a.m. Eastern Time. Investors and other interested parties are invited to register and access a live webcast of the presentation by following this link. Following the event, an archived webcast of the presentation will be available at investor.singulargenomics.com, in the News & Events section.

About Singular Genomics Systems, Inc.
Singular Genomics is a life science technology company that develops next-generation sequencing and multiomics technologies. The commercially available G4 Sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. In development, the PX system leverages Singular’s proprietary sequencing technology, applying it as an in-situ readout to look at RNA and proteins in single cells and tissue. With these products, Singular Genomics’ mission is to empower researchers and clinicians to advance science and medicine.

Investor Contact
Matt Clawson
949-370-8500
ir@singulargenomics.com

Media Contact
Dan Budwick, 1AB
973-271-6085
dan@1abmedia.com

FAQ

When is Singular Genomics presenting at the Gilmartin Group Showcase?

Singular Genomics will present on August 31, 2022, at 7:30 a.m. PT / 10:30 a.m. ET.

How can I access the Singular Genomics presentation?

Investors can register for the live webcast of the presentation through a provided link in the press release.

What technologies does Singular Genomics focus on?

Singular Genomics focuses on next-generation sequencing (NGS) and multiomics technologies.

What is the G4 Sequencing Platform?

The G4 Sequencing Platform is a benchtop genomic sequencer developed by Singular Genomics that provides fast and accurate results.

Where can I find the archived presentation after the event?

The archived presentation will be available in the News & Events section on Singular Genomics' investor website.